← Leaderboards
James T Rosenbaum
Oregon Health And Science University
$22,148,617
Attributed
$23,485,571
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–21$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$33,350,673 · 13
By mechanism
R01$21,877,353 · 10
P30$9,865,102 · 1
T32$1,350,651 · 1
M01$257,567 · 1
Top collaborators
- Holly Lallman Rosenzweig4 shared
- Mark Asquith3 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Tammy M Martin$4,039,697
- William D Mathers$673,247
- Grazyna Adamus$4,345,889
- Ellen J Lee$554,289
Others in their field
Top investigators on “Uveitis”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Janet T. Holbrook · Johns Hopkins University$46,477,725
- Raymond Kraker · Jaeb Center For Health Research, Inc.$27,627,512
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Nisha Acharya · University Of California, San Francisco$11,276,781
- Keri, Hammel · The Emmes Company, Llc$11,064,901
Research focus
UveitisInflammationGene ExpressionBlindnessMediatingAnterior UveitisImmuneInflammatoryPathogenesisSarcoidosisGenesDiagnosisAffectCytokineTissuesAnteriorIntravital MicroscopyBaseCell Adhesion MoleculesUveaBloodGene Expression ProfileFundingMorbidity - Disease Rate
Grant awards (78)
The Gut Microbiome and HLA B27-associated Acute Anterior Uveitis$363,252
R01 · FY2021 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$649,406
R01 · FY2020 · EY · contact PI
The Gut Microbiome and HLA B27-associated Acute Anterior Uveitis$408,186
R01 · FY2020 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$649,406
R01 · FY2019 · EY · contact PI
Characterizing Uveitis by Gene Expression$385,000
R01 · FY2019 · EY · contact PI
The Gut Microbiome and HLA B27-associated Acute Anterior Uveitis$378,186
R01 · FY2019 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$649,406
R01 · FY2018 · EY · contact PI
Characterizing Uveitis by Gene Expression$385,000
R01 · FY2018 · EY · contact PI
The Gut Microbiome and HLA B27-associated Acute Anterior Uveitis$374,486
R01 · FY2018 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$649,406
R01 · FY2017 · EY · contact PI
Characterizing Uveitis by Gene Expression$385,000
R01 · FY2017 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$652,486
R01 · FY2016 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$120,936
P30 · FY2015 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$725,614
P30 · FY2014 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$428,656
R01 · FY2014 · EY · contact PI
Understanding uveitis in a multi-system disease model of spondyloarthropathy$377,300
R01 · FY2014 · EY
OPHTHALMOLOGY CORE FACILITY$730,026
P30 · FY2013 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$415,534
R01 · FY2013 · EY · contact PI
Understanding uveitis in a multi-system disease model of spondyloarthropathy$365,750
R01 · FY2013 · EY
OPHTHALMOLOGY CORE FACILITY$734,309
P30 · FY2012 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$437,403
R01 · FY2012 · EY · contact PI
Understanding uveitis in a multi-system disease model of spondyloarthropathy$385,000
R01 · FY2012 · EY
OPHTHALMOLOGY CORE FACILITY$738,469
P30 · FY2011 · EY · contact PI
Gene Expression in Nonspecific Orbital Inflammatory Disease$437,403
R01 · FY2011 · EY · contact PI
Understanding uveitis in a multi-system disease model of spondyloarthropathy$385,000
R01 · FY2011 · EY
OPHTHALMOLOGY CORE FACILITY$732,368
P30 · FY2010 · EY · contact PI
Four Dimensional Imaging of the Immune Response in Vivo$575,364
R01 · FY2010 · EY · contact PI
Endotoxin-induced Uveitis Revisited$474,972
R01 · FY2010 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$577,500
P30 · FY2009 · EY · contact PI
Four Dimensional Imaging of the Immune Response in Vivo$569,901
R01 · FY2009 · EY · contact PI
Endotoxin-induced Uveitis Revisited$463,894
R01 · FY2009 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$577,500
P30 · FY2008 · EY · contact PI
Four Dimensional Imaging of the Immune Response in Vivo$547,122
R01 · FY2008 · EY · contact PI
UVEITIS GENE-EXPRESSION PROFILING$498,292
R01 · FY2008 · EY · contact PI
CHEMOTACTIC FACTORS IN ANIMAL MODELS OF UVEITIS$359,234
R01 · FY2008 · EY · contact PI
Four Dimensional Imaging of the Immune Response in Vivo$617,744
R01 · FY2007 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$577,188
P30 · FY2007 · EY · contact PI
UVEITIS GENE-EXPRESSION PROFILING$495,553
R01 · FY2007 · EY · contact PI
CHEMOTACTIC FACTORS IN ANIMAL MODELS OF UVEITIS$366,565
R01 · FY2007 · EY · contact PI
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$49,754
T32 · FY2007 · EY · contact PI
Four Dimensional Imaging of the Immune Response in Vivo$591,096
R01 · FY2006 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$575,001
P30 · FY2006 · EY · contact PI
UVEITIS GENE-EXPRESSOIN PROFILING$484,172
R01 · FY2006 · EY · contact PI
CHEMOTACTIC FACTORS IN ANIMAL MODELS OF UVEITIS$368,629
R01 · FY2006 · EY · contact PI
OPHTHALMOLOGY CORE FACILITY$566,250
P30 · FY2005 · EY
UVEITIS GENE-EXPRESSION PROFILING$489,419
R01 · FY2005 · EY
CHEMOTACTIC FACTORS IN ANIMAL MODELS OF UVEITIS$377,500
R01 · FY2005 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$259,473
T32 · FY2005 · EY
"REMICADE" IN THE MANAGEMENT OF VISION-THREATENING UVEITIS$47,880
M01 · FY2005 · RR
OPTHALMOLOGY CORE FACILITY$807,953
P30 · FY2004 · EY
CHEMOTACTIC FACTORS IN ANIMAL MODELS OF UVEITIS$377,500
R01 · FY2004 · EY
Anterior Uveal Dendritic Cells$302,000
R01 · FY2004 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$259,473
T32 · FY2004 · EY
"Remicade" in the Management of Vision-Threatening Uveitis$37,276
M01 · FY2004 · RR
OPTHALMOLOGY CORE FACILITY$775,210
P30 · FY2003 · EY
FOUR DIMENTIONAL IMAGING OF THE IMMUNE RESPONSE IN VIVO$528,500
R01 · FY2003 · EY
CHEMOTACTIC FACTORS IN MODELS OF UVEITIS$373,604
R01 · FY2003 · EY
Anterior Uveal Dendritic Cells$302,000
R01 · FY2003 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$253,395
T32 · FY2003 · EY
OPTHALMOLOGY CORE FACILITY$754,750
P30 · FY2002 · EY
FOUR DIMENTIONAL IMAGING OF THE IMMUNE RESPONSE IN VIVO$528,500
R01 · FY2002 · EY
CHEMOTACTIC FACTORS IN MODELS OF UVEITIS$362,723
R01 · FY2002 · EY
Anterior Uveal Dendritic Cells$302,000
R01 · FY2002 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$239,696
T32 · FY2002 · EY
FOUR DIMENTIONAL IMAGING OF THE IMMUNE RESPONSE IN VIVO$528,500
R01 · FY2001 · EY
OPTHALMOLOGY CORE FACILITY$373,725
P30 · FY2001 · EY
CHEMOTACTIC FACTORS IN MODELS OF UVEITIS$352,159
R01 · FY2001 · EY
Anterior Uveal Dendritic Cells$302,000
R01 · FY2001 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$225,665
T32 · FY2001 · EY
UTILITY OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF UVEITIS$172,411
M01 · FY2001 · RR
OPHTHALMOLOGY CORE FACILITY SUPPLEMENT$124,575
P30 · FY2001 · EY
UTILITY OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF UVEITIS$0
M01 · FY2001 · RR
FOUR DIMENTIONAL IMAGING OF THE IMMUNE RESPONSE IN VIVO$528,500
R01 · FY2000 · EY
OPTHALMOLOGY CORE FACILITY$373,728
P30 · FY2000 · EY
CHEMOTACTIC FACTORS IN MODELS OF UVEITIS$341,902
R01 · FY2000 · EY
ENDOTOXIN INDUCED UVEITIS$306,742
R01 · FY2000 · EY
IMMUNOLOGY/MOLECULAR BIOLOGY TRAINING IN OPHTHALMOLOGY$63,195
T32 · FY2000 · EY
UTILITY OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF UVEITIS$0
M01 · FY2000 · RR